Review article · 2025 · Open access

PROTAC delivery systems: Innovative approaches for cancer treatment

María Arenas-Moreira, Alberto Ocaña, Iván Bravo, Carlos Alonso‐Moreno

Biomedicine & Pharmacotherapy, 194, 118892 · Published 12 December 2025 · DOI 10.1016/j.biopha.2025.118892

Open full textCite this paper

In brief

“PROTAC delivery systems: Innovative approaches for cancer treatment” is a 2025 review article by María Arenas-Moreira and 3 co-authors, published in Biomedicine & Pharmacotherapy. OpenAlex counts 11 citations as of 19 November 2026, which puts it in the top 2% of works published in 2025 by citations. It is open access under a CC BY-NC-ND licence: the full text is free to read at Biomedicine & Pharmacotherapy.

Citations
11
Most cited in
2026 (11)
Field-weighted impact
0.64
References
123
Authors
4

Abstract

To date, several targeted therapies have been developed for their clinical use, exhibiting increased cancer cell specificity. PROteolysis TArgeting Chimeras (PROTACs) are small molecules designed to induce the degradation of target proteins via proteasome after their ubiquitination. These molecules represent the most recent strategy of targeting specific proteins for post-translational degradation rather than simply inhibiting them. Despite the promising efficacy of PROTAC-based targeted therapies, significant drawbacks remain regarding their clinical translation. Advances in drug delivery systems (DDS) and nanotechnology offer innovative strategies to overcome these limitations and optimize the therapeutic index of PROTACs, through the use of several nanocarriers including lipid-based nanoparticles, polymeric nanoparticles or metallic nanoparticles, among others. In light of the exponential growth of preclinical studies, this review summarizes key achievements in the development of PROTACs and nanoPROTACs, highlighting how DDS can improve their mechanism of action and facilitate future clinical applications. Furthermore, recent research has focused on addressing critical challenges related to the permeability, bioavailability, and toxicity of these molecules, paving the way for more effective and safer therapeutic options. Continued interdisciplinary efforts integrating medicinal chemistry, nanotechnology and oncology are essential to fully exploit the potential of PROTACs.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Arenas-Moreira, M., Ocaña, A., Bravo, I., & Alonso‐Moreno, C. (2025). PROTAC delivery systems: Innovative approaches for cancer treatment. Biomedicine & Pharmacotherapy, 194, 118892. https://doi.org/10.1016/j.biopha.2025.118892

MLA 9

Arenas-Moreira, María, et al. “PROTAC delivery systems: Innovative approaches for cancer treatment.” Biomedicine & Pharmacotherapy, vol. 194, 2025, p. 118892. https://doi.org/10.1016/j.biopha.2025.118892.

Chicago

Arenas-Moreira, María, Alberto Ocaña, Iván Bravo, and Carlos Alonso‐Moreno. 2025. “PROTAC delivery systems: Innovative approaches for cancer treatment.” Biomedicine & Pharmacotherapy 194: 118892. https://doi.org/10.1016/j.biopha.2025.118892.

Harvard

Arenas-Moreira, M. et al. (2025) ‘PROTAC delivery systems: Innovative approaches for cancer treatment’, Biomedicine & Pharmacotherapy, 194, p. 118892. doi:10.1016/j.biopha.2025.118892.

IEEE

M. Arenas-Moreira, A. Ocaña, I. Bravo, and C. Alonso‐Moreno, “PROTAC delivery systems: Innovative approaches for cancer treatment,” Biomedicine & Pharmacotherapy, vol. 194, p. 118892, 2025, doi: 10.1016/j.biopha.2025.118892.

BibTeX

@article{arenasmoreira2025protac,
  title     = {{PROTAC delivery systems: Innovative approaches for cancer treatment}},
  author    = {Arenas-Moreira, María and Ocaña, Alberto and Bravo, Iván and Alonso‐Moreno, Carlos},
  journal   = {Biomedicine \& Pharmacotherapy},
  year      = {2025},
  volume    = {194},
  pages     = {118892},
  doi       = {10.1016/j.biopha.2025.118892},
  url       = {https://doi.org/10.1016/j.biopha.2025.118892}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors

  • PROTACs
  • drug delivery systems
  • protein degradation
  • ubiquitination
  • proteasome
  • nanocarriers
  • lipid nanoparticles
  • polymeric nanoparticles

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Arenas-Moreira, M., Ocaña, A., Bravo, I., & Alonso‐Moreno, C. (2025). PROTAC delivery systems: Innovative approaches for cancer treatment. Biomedicine & Pharmacotherapy, 194, 118892. https://doi.org/10.1016/j.biopha.2025.118892

How many times has this paper been cited?

11 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Biomedicine & Pharmacotherapy: sign in and open the full text from this page.

Who wrote this paper?

María Arenas-Moreira, Alberto Ocaña, Iván Bravo, Carlos Alonso‐Moreno.

What is the DOI of this paper?

10.1016/j.biopha.2025.118892, permanently at https://doi.org/10.1016/j.biopha.2025.118892. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.